194 related articles for article (PubMed ID: 38002548)
21. Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus.
Alolayan YS; McKinley K; Bhatia R; Alkhachroum A
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300194
[TBL] [Abstract][Full Text] [Related]
22. Isoflurane treatment for refractory and super-refractory status epilepticus in dogs.
Sarpekidou E; Polyzois G; Papageorgiou V; Savvas I; Polizopoulou Z; Kazakos G
Front Vet Sci; 2024; 11():1338894. PubMed ID: 38523714
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic hypothermia for pediatric refractory status epilepticus May Ameliorate post-status epilepticus epilepsy.
Hsu MH; Kuo HC; Lin JJ; Chou MY; Lin YJ; Hung PL
Biomed J; 2020 Jun; 43(3):277-284. PubMed ID: 32330677
[TBL] [Abstract][Full Text] [Related]
24. Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
Bonardi CM; Furlanis GM; Toldo I; Guarrera B; Luisi C; Pettenazzo A; Nosadini M; Boniver C; Sartori S; Landi A
Brain Dev; 2023 May; 45(5):293-299. PubMed ID: 36725381
[TBL] [Abstract][Full Text] [Related]
25. Super-refractory status epilepticus in West China.
Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D
Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275
[TBL] [Abstract][Full Text] [Related]
26. Super-refractory status epilepticus (SRSE): A case series of 22 pediatric patients.
Caputo D; Santarone ME; Serino D; Pietrafusa N; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2022 Mar; 37():25-31. PubMed ID: 35032870
[TBL] [Abstract][Full Text] [Related]
27. Incidence and mortality of super-refractory status epilepticus in adults.
Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
[TBL] [Abstract][Full Text] [Related]
28. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
[TBL] [Abstract][Full Text] [Related]
29. Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience.
Singh RK; Singh R; Stewart A; Van Poppel K; Klinger S; Hulihan J; Van Heusen H; Vaitkevicius H; Gasior M
Epilepsy Behav Rep; 2022; 20():100567. PubMed ID: 36325100
[TBL] [Abstract][Full Text] [Related]
30. New onset refractory status epilepticus (NORSE).
Sculier C; Gaspard N
Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
[TBL] [Abstract][Full Text] [Related]
31. Deep brain stimulation for the treatment of refractory and super-refractory status epilepticus.
Sobstyl M; Stapińska-Syniec A; Rylski M
Seizure; 2020 Oct; 81():58-62. PubMed ID: 32745949
[TBL] [Abstract][Full Text] [Related]
32. Electroconvulsive therapy use for refractory status epilepticus in an implantable vagus nerve stimulation patient: A case report.
Katzell L; Beydler EM; Holbert R; Rodriguez-Roman L; Carr BR
Front Psychiatry; 2023; 14():1126956. PubMed ID: 36816412
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes after NORSE: Treatment with vagus nerve stimulation.
Espino PH; Burneo JG; Moscol G; Gofton T; MacDougall K; Suller Marti A
Epilepsia Open; 2022 Dec; 7(4):822-828. PubMed ID: 36177520
[TBL] [Abstract][Full Text] [Related]
34. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
Stetefeld HR; Schaal A; Scheibe F; Nichtweiß J; Lehmann F; Müller M; Gerner ST; Huttner HB; Luger S; Fuhrer H; Bösel J; Schönenberger S; Dimitriadis K; Neumann B; Fuchs K; Fink GR; Malter MP;
Neurocrit Care; 2021 Dec; 35(3):631-639. PubMed ID: 34286464
[TBL] [Abstract][Full Text] [Related]
35. Neuromodulation in new-onset refractory status epilepticus.
Stavropoulos I; Khaw JH; Valentin A
Front Neurol; 2023; 14():1195844. PubMed ID: 37388544
[TBL] [Abstract][Full Text] [Related]
36. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
[TBL] [Abstract][Full Text] [Related]
37. How much refractory is 'refractory status epilepticus'? A retrospective study of treatment strategies and clinical outcomes.
Lattanzi S; Giovannini G; Orlandi N; Brigo F; Trinka E; Meletti S
J Neurol; 2023 Dec; 270(12):6133-6140. PubMed ID: 37587268
[TBL] [Abstract][Full Text] [Related]
38. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
[No Abstract] [Full Text] [Related]
40. Use of Continuous Ketamine Infusion as an Adjunctive Agent in Young Infants With Refractory and Super Refractory Status Epilepticus: A Case Series.
DeVine MN; Gordon SE; Press CA
J Pediatr Pharmacol Ther; 2023; 28(2):161-166. PubMed ID: 37139250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
